• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

假结核耶尔森菌中的一种磷酸二酯酶CpdB可降解环二核苷酸以抑制先天免疫反应。

A phosphodiesterase CpdB in Yersinia pseudotuberculosis degrades CDNs to inhibit innate immune response.

作者信息

Wang Xiao, Hao Xinwei, Yang Yuqing, Jia Siyu, Chen Yating, Yang Wenguang, Luo Yi, Xie Zhen, Gu Yanchao, Wu Yuxuan, Zhang Fuhua, Li Mengyuan, Wang Yao, Shen Xihui, Xu Lei

机构信息

State Key Laboratory for Crop Stress Resistance and High-Efficiency Production, Shaanxi Key Laboratory of Agricultural and Environmental Microbiology, College of Life Sciences, Northwest A&F University, Yangling, Shaanxi 712100, China.

State Key Laboratory for Crop Stress Resistance and High-Efficiency Production, Shaanxi Key Laboratory of Agricultural and Environmental Microbiology, College of Life Sciences, Northwest A&F University, Yangling, Shaanxi 712100, China.

出版信息

Vet Microbiol. 2024 Oct;297:110194. doi: 10.1016/j.vetmic.2024.110194. Epub 2024 Jul 22.

DOI:10.1016/j.vetmic.2024.110194
PMID:39084162
Abstract

Yersinia pseudotuberculosis (Yptb) is a pathogenic gram-negative bacterium that can colonize the intestines of different animals. Its infection leads to the activation of the host's innate immunity. Both host and bacterial-derived cyclic dinucleotides (CDNs) could activate the innate immune response of host cells. In bacteria, CDNs like c-di-AMP, c-di-GMP, or 3'3'-cGAMP can be hydrolyzed by different hydrolases. Recent studies showed that the degradation of those second messengers helps the pathogen evade immune detection. In this study, we identified a hydrolase, YPK_3776, namely CpdB in Yptb. CpdB is predicted to bind bacterial-derived c-di-AMP, c-di-GMP, 3'3'-cGAMP and host-derived 2'3'-cGAMP. Surprisingly, by using high-performance liquid chromatography (HPLC), we found that CpdB could only degrade bacterial-derived CDNs but not host-derived 2'3'-cGAMP. In addition, CpdB has 2'3'-cNMP activity. Consistently, the Yptb mutant lacking the cpdB gene exhibited a higher level of intracellular c-di-GMP. Furthermore, the ∆cpdB mutant elicited stronger innate immune responses during Yptb infection in macrophages, suggesting CpdB enables Yptb to evade host immune surveillance. Furthermore, CpdB inhibited the Yptb-induced innate immune response in a STING-dependent manner. Finally, we showed the ∆cpdB infection in mice model exhibited in lower bacterial burden, as compared to wild-type strain infection, indicating CpdB is important for bacterial survival in the host. Together, we identified a cyclic dinucleotide hydrolase CpdB in Yptb that could degrade bacterial-derived CDNs which help the pathogen to evade immune detection via the STING pathway.

摘要

假结核耶尔森菌(Yptb)是一种致病性革兰氏阴性细菌,可在不同动物的肠道中定殖。其感染会导致宿主先天免疫的激活。宿主和细菌来源的环二核苷酸(CDN)均可激活宿主细胞的先天免疫反应。在细菌中,像环二腺苷酸(c-di-AMP)、环二鸟苷酸(c-di-GMP)或3'3'-环鸟苷酸腺苷酸(3'3'-cGAMP)这样的CDN可被不同的水解酶水解。最近的研究表明,这些第二信使的降解有助于病原体逃避免疫检测。在本研究中,我们鉴定了一种水解酶,即Yptb中的YPK_3776,也就是CpdB。预测CpdB可结合细菌来源的c-di-AMP、c-di-GMP、3'3'-cGAMP以及宿主来源的2'3'-cGAMP。令人惊讶的是,通过高效液相色谱(HPLC),我们发现CpdB只能降解细菌来源的CDN,而不能降解宿主来源的2'3'-cGAMP。此外,CpdB具有2'3'-环核苷酸单磷酸(2'3'-cNMP)活性。一致的是,缺失cpdB基因的Yptb突变体表现出更高水平的细胞内环二鸟苷酸。此外,在巨噬细胞感染Yptb期间,∆cpdB突变体引发了更强 的先天免疫反应,这表明CpdB使Yptb能够逃避宿主免疫监视。此外,CpdB以一种依赖于干扰素基因刺激蛋白(STING)的方式抑制Yptb诱导的先天免疫反应。最后,我们发现与野生型菌株感染相比,在小鼠模型中∆cpdB感染的细菌载量更低,这表明CpdB对细菌在宿主体内的存活很重要。总之,我们在Yptb中鉴定了一种环二核苷酸水解酶CpdB,它可以降解细菌来源的CDN,这有助于病原体通过STING途径逃避免疫检测。

相似文献

1
A phosphodiesterase CpdB in Yersinia pseudotuberculosis degrades CDNs to inhibit innate immune response.假结核耶尔森菌中的一种磷酸二酯酶CpdB可降解环二核苷酸以抑制先天免疫反应。
Vet Microbiol. 2024 Oct;297:110194. doi: 10.1016/j.vetmic.2024.110194. Epub 2024 Jul 22.
2
Structures of c-di-GMP/cGAMP degrading phosphodiesterase VcEAL: identification of a novel conformational switch and its implication.c-di-GMP/cGAMP 降解磷酸二酯酶 VcEAL 的结构:一种新型构象开关的鉴定及其意义。
Biochem J. 2019 Nov 15;476(21):3333-3353. doi: 10.1042/BCJ20190399.
3
YopJ Limits Macrophage Response by Downregulating COX-2-Mediated Biosynthesis of PGE2 in a MAPK/ERK-Dependent Manner.YopJ 通过依赖于 MAPK/ERK 的方式下调 COX-2 介导的 PGE2 生物合成来限制巨噬细胞反应。
Microbiol Spectr. 2021 Sep 3;9(1):e0049621. doi: 10.1128/Spectrum.00496-21. Epub 2021 Jul 28.
4
c-di-GMP Induces COX-2 Expression in Macrophages in a STING-Independent Manner.c-di-GMP 以 STING 非依赖的方式诱导巨噬细胞中 COX-2 的表达。
ACS Chem Biol. 2021 Sep 17;16(9):1663-1670. doi: 10.1021/acschembio.1c00342. Epub 2021 Sep 3.
5
A role for Toll-like receptor 4 in the host response to the lung infection of Yersinia pseudotuberculosis in mice.Toll样受体4在小鼠对假结核耶尔森菌肺部感染的宿主反应中的作用。
Comp Immunol Microbiol Infect Dis. 2016 Feb;44:54-60. doi: 10.1016/j.cimid.2016.01.001. Epub 2016 Jan 8.
6
BarA-UvrY Two-Component Regulatory System Represses Biofilms via CsrB.BarA-UvrY 双组分调控系统通过 CsrB 抑制生物膜形成。
Front Cell Infect Microbiol. 2018 Sep 18;8:323. doi: 10.3389/fcimb.2018.00323. eCollection 2018.
7
CCR2 Inflammatory Monocytes Are Recruited to Yersinia pseudotuberculosis Pyogranulomas and Dictate Adaptive Responses at the Expense of Innate Immunity during Oral Infection.CCR2 炎性单核细胞被招募到假结核耶尔森菌脓性肉芽肿中,并以牺牲固有免疫为代价,决定适应性反应,在口服感染期间。
Infect Immun. 2018 Feb 20;86(3). doi: 10.1128/IAI.00782-17. Print 2018 Mar.
8
Mass spectrometric characterization of cyclic dinucleotides (CDNs) in vivo.体内环状二核苷酸(CDNs)的质谱特征分析。
Anal Bioanal Chem. 2021 Nov;413(26):6457-6468. doi: 10.1007/s00216-021-03628-6. Epub 2021 Sep 2.
9
Innate immune recognition of Yersinia pseudotuberculosis type III secretion.天然免疫识别耶尔森氏菌假结核型 III 型分泌系统。
PLoS Pathog. 2009 Dec;5(12):e1000686. doi: 10.1371/journal.ppat.1000686. Epub 2009 Dec 4.
10
Chemical synthesis, purification, and characterization of 3'-5'-linked canonical cyclic dinucleotides (CDNs).3'-5'-连接的标准环二核苷酸(CDNs)的化学合成、纯化及表征
Methods Enzymol. 2019;625:41-59. doi: 10.1016/bs.mie.2019.04.022. Epub 2019 May 20.